Market Cap

BioArctic AB Market Capitalization:

kr23.65 Billion

SEK as of Jan. 1, 2024

US$2.35 Billion

business BioArctic AB Company Profile

BioArctic AB Main Stock Listing

OMX: BIOA.B

Market Capitalization History of BioArctic AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of BioArctic AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr23.65 B -11.92%
Jan. 1, 2023 kr26.85 B 199.26%
Jan. 1, 2022 kr8.97 B 5.47%
Jan. 1, 2021 kr8.51 B 13.27%
Jan. 1, 2020 kr7.51 B 5.79%
Jan. 1, 2019 kr7.10 B 205.18%
Jan. 1, 2018 kr2.33 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

BioArctic AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

BioArctic AB has the following listings and related stock indices.


Stock: OMX: BIOA.B

Stock: FSX: B9A

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.